PHENYLEPHRINE 2.5 %
PHENYLEPHRINE HYDROCHLORIDE : 2.5 % · DIN 02027100 · PHARMA STULLN INC.
Health Canada status: DORMANT
What is PHENYLEPHRINE?
PHENYLEPHRINE 2.5 % contains PHENYLEPHRINE HYDROCHLORIDE : 2.5 %. It is listed in the Health Canada Drug Product Database under DIN 02027100, held by PHARMA STULLN INC., supplied as SOLUTION for OPHTHALMIC administration. Health Canada currently lists it as dormant, status dated 21-Jan-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02027100 |
|---|---|
| Brand name | PHENYLEPHRINE |
| Generic / active ingredient | PHENYLEPHRINE HYDROCHLORIDE : 2.5 % |
| Manufacturer | PHARMA STULLN INC. |
| Strength | 2.5 % |
| Dosage form | SOLUTION |
| Route of administration | OPHTHALMIC |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | S01FB01 PHENYLEPHRINE |
| AHFS class | 38:00.00 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 21-Jan-2020 |
| Original market date | 1993-12-31 00:00:00 |
Is PHENYLEPHRINE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code S01FB01 PHENYLEPHRINE. 3 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MINIMS PHENYLEPHRINE HYDROCHLORIDE | 10 % | SOLUTION | BAUSCH & LOMB INC | MARKETED | DIN 02148455 |
| MINIMS PHENYLEPHRINE HYDROCHLORIDE | 2.5 % | SOLUTION | BAUSCH & LOMB INC | MARKETED | DIN 02148447 |
| MYDFRIN | 2.5 % | SOLUTION | ALCON CANADA INC | MARKETED | DIN 00465763 |
| ODAN-PHENYLEPHRINE | 2.5 % | SOLUTION | ODAN LABORATORIES LTD | DORMANT | DIN 00622915 |
Who else supplies PHENYLEPHRINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PHENYLEPHRINE appears in 51 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.